Ryman Healthcare Limited (RYM.NZ)
NZD 4.38
(-0.45%)
NZD 4.38
(-0.45%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 650.53 Million | 560.11 Million | 503.75 Million | 452.41 Million | 422.11 Million | 380.94 Million |
| Cost of Revenue | 651.88 Million | 579.87 Million | 501.93 Million | 427.67 Million | 377.86 Million | 326.87 Million |
| Gross Profit | -1.34 Million | -19.76 Million | 1.82 Million | 24.73 Million | 44.24 Million | 54.07 Million |
| Operating Expenses | 650.53 Million | 579.87 Million | 501.93 Million | 427.67 Million | 377.86 Million | 326.87 Million |
| Selling, General and Administrative Expenses | 463.91 Million | - | 305.75 Million | 265.49 Million | 233.54 Million | 212.51 Million |
| Research and Development Expenses | - | 11.74 Million | 5.1 Million | 5.13 Million | 3.6 Million | - |
| Other Expenses | - | 440.23 Million | 750.88 Million | 420.12 Million | 145.66 Million | 293.76 Million |
| Cost and Expenses | 695.68 Million | 579.87 Million | 501.93 Million | 427.67 Million | 377.86 Million | 326.87 Million |
| Operating Income | -69.6 Million | 422.41 Million | 752.54 Million | 444.59 Million | 190.21 Million | 348.37 Million |
| Interest Expense | 50.39 Million | 205.18 Million | 30.46 Million | 18.99 Million | 19.06 Million | 18.95 Million |
| Income Tax Expense | -149.7 Million | -51.64 Million | 29.2 Million | -12.56 Million | -93.56 Million | 3.42 Million |
| Earnings before Tax | -144.92 Million | 206.19 Million | 722.08 Million | 410.5 Million | 171.14 Million | 329.41 Million |
| Net Income | 4.77 Million | 257.83 Million | 692.87 Million | 423.06 Million | 264.71 Million | 325.98 Million |
| Earnings Per Share Basic | 0.01 | 0.50 | 1.31 | 0.80 | 0.50 | 0.61 |
| Earnings Per Share Diluted | 0.01 | 0.50 | 1.31 | 0.80 | 0.50 | 0.61 |
| Weighted Average Shares Outstanding | 687.64 Million | 516.32 Million | 530.45 Million | 530.45 Million | 530.45 Million | 530.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 687.64 Million | 516.32 Million | 530.45 Million | 530.45 Million | 530.45 Million | 530.43 Million |
| Gross Margin | -0.00 | -0.04 | 0.00 | 0.05 | 0.10 | 0.14 |
| EBIT Margin | -0.14 | 0.84 | 1.56 | 1.05 | 0.52 | 0.98 |
| Profit Margin | 0.01 | 0.46 | 1.38 | 0.94 | 0.63 | 0.86 |
| EBITDA | -91.21 Million | 264.79 Million | 788.44 Million | 462.23 Million | 219.07 Million | 371.49 Million |
| Earnings Before Tax Margin | -0.11 | 0.75 | 1.49 | 0.98 | 0.45 | 0.91 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 650.53 Million | 182.93 Million | 182.93 Million | 316.67 Million | 160.84 Million | 290.17 Million |
| Cost of Revenue | 695.68 Million | 179.51 Million | 179.51 Million | 319.04 Million | 146.42 Million | 291.73 Million |
| Gross Profit | -45.15 Million | 3.42 Million | 3.42 Million | -2.37 Million | 14.41 Million | -1.55 Million |
| Operating Expenses | 720.14 Million | 123.81 Million | 123.81 Million | 67.51 Million | 67.51 Million | 33.43 Million |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | 8.03 Million | 8.03 Million | - | - | 5.87 Million |
| Other Expenses | 216.57 Million | - | - | - | - | - |
| Cost and Expenses | 695.68 Million | 303.32 Million | 303.32 Million | 319.04 Million | 213.94 Million | 291.73 Million |
| Operating Income | -45.15 Million | -5.38 Million | -5.38 Million | -2.37 Million | 1.32 Million | -1.55 Million |
| Interest Expense | 50.39 Million | - | - | 21.7 Million | - | 186.01 Million |
| Income Tax Expense | -149.7 Million | 53.22 Million | 53.22 Million | -43.25 Million | 21.62 Million | -74.95 Million |
| Earnings before Tax | -144.92 Million | -144.18 Million | -144.18 Million | 143.43 Million | 71.71 Million | -11.1 Million |
| Net Income | 4.77 Million | -90.95 Million | -90.95 Million | 186.68 Million | 93.34 Million | 63.85 Million |
| Earnings Per Share Basic | - | -0.13 | -0.13 | 0.27 | 0.14 | 0.11 |
| Earnings Per Share Diluted | - | -0.13 | -0.13 | 0.27 | 0.14 | 0.11 |
| Weighted Average Shares Outstanding | 687.64 Million | 687.64 Million | 687.64 Million | 687.64 Million | 687.64 Million | 573.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 687.64 Million | 687.64 Million | 687.64 Million | 687.64 Million | 687.64 Million | 573.17 Million |
| Gross Margin | -0.07 | 0.02 | 0.02 | -0.01 | 0.09 | -0.01 |
| EBIT Margin | - | 0.00 | 0.01 | 0.08 | 0.08 | 0.08 |
| Profit Margin | 0.01 | -0.50 | -0.50 | 0.59 | 0.58 | 0.22 |
| EBITDA | - | 603.75 Thousand | 2.66 Million | 23.81 Million | 13.48 Million | 22.04 Million |
| Earnings Before Tax Margin | -0.07 | -0.03 | -0.03 | -0.01 | 0.01 | -0.01 |
AZZ
LL
002443
0772
ACBD
HERO